The profit after the tax increased to $ 7 billion last year, which is USD $ 6 billion in 2023, the company said, noting a sudden increase in cancer drug sales. Read more
Source link
The profit after the tax increased to $ 7 billion last year, which is USD $ 6 billion in 2023, the company said, noting a sudden increase in cancer drug sales. Read more
Source link
